adenosine diphosphate has been researched along with amifostine anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grignani, G; Maiolo, A; Porta, C; Tua, A | 1 |
| Anfossi, G; Massucco, P; Mattiello, L; Russo, I; Trovati, M | 1 |
2 other study(ies) available for adenosine diphosphate and amifostine anhydrous
| Article | Year |
|---|---|
Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Topics: Adenosine Diphosphate; Adult; Amifostine; Antioxidants; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Radiation-Protective Agents; Reactive Oxygen Species; Thromboxane B2 | 2000 |
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects.
Topics: Acetylcysteine; Adenosine Diphosphate; Adult; Amifostine; Antioxidants; Collagen; Cyclic GMP; Drug Resistance; Female; Free Radical Scavengers; Humans; Insulin Resistance; Male; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Superoxide Dismutase | 2003 |